Acadia Pharmaceuticals (ACAD) Other Non-Current Assets (2010 - 2026)

Acadia Pharmaceuticals' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 10.54% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (down 10.54% YoY), while the FY2025 annual figure was $3.9 million, down 55.58% from the prior year.
• Other Non-Current Assets was $7.8 million for Q1 2026 at Acadia Pharmaceuticals, up from $3.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9.5 million in Q2 2025 to a low of $3.0 million in Q3 2025.
• Historically, Other Non-Current Assets has averaged $6.5 million across 5 years, with a median of $5.8 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 86.13% in 2022, then slumped 65.86% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $5.8 million in 2022, then changed by 0.0% to $5.8 million in 2023, then surged by 51.99% to $8.8 million in 2024, then tumbled by 55.58% to $3.9 million in 2025, then jumped by 101.39% to $7.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $7.8 million (Q1 2026), $3.9 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.